prostate cancer

by Uppsala University edited by Lisa Lock, reviewed by Robert Egan   Original biopsy (top) and a color-coded biopsy (bottom). The warm colors in the bottom image show abnormal patterns indicating cancer. Credit: Carolina Wählby Men assessed as healthy after a pathologist analyzes their tissue sample may still have an early form of prostate cancer. Using AI, researchers […]

by Emory University edited by Sadie Harley, reviewed by Andrew Zinin  Two proteins, FOXA2 and NKX2-1, play a central role in the process of reprogramming the cancer cells into a deadlier form, NEPC, turning on a new set of oncogenes via p300. CCS1477 is a type of inhibiting drug that could target the moving targets, thus stop the

Fralin Biomedical Research Institute scientists part of international team that discovers how prostate cancer turns immune cells into accomplices Peer-Reviewed Publication Virginia Tech FacebookXLinkedInWeChatBlueskyMessageWhatsAppEmail image: Shenglin Mei of Virginia Tech’s Fralin Biomedical Research Institute was part of a multi-institutional team including researchers from Harvard Medical School, Massachusetts General Hospital, the University of Chicago, and Sweden’s Karolinska

by Virginia Tech edited by Sadie Harley, reviewed by Robert Egan Credit: CC0 Public Domain Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow—and how blocking them could help the body fight back. The study, published in Molecular Cancer Research, identifies a group of cells called macrophages that, instead of protecting the body, appear to shield

by University of Eastern Finland edited by Gaby Clark, reviewed by Robert Egan   Coactivation of AR and GR influences a distinct population of single cells. Credit: Genome Research (2025). DOI: 10.1101/gr.280224.124 A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending

by Lori Solomon edited by Sadie Harley, reviewed by Andrew Zinin   Acupuncture may reduce nocturia in patients treated for prostate cancer, according to a research letter published online in JAMA Oncology. Kevin T. Liou, M.D., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues conducted a randomized trial to evaluate acupuncture (10 weekly standardized treatments)